San Carlos, United States
Range Biotechnologies, founded in 2022, is a pioneering company in the Biotechnology, Health Care, and Life Sciences industries. Headquartered in the United States, the company is focused on leveraging translational proteomics to advance human health. Their slogan, "Translational proteomics for the next stage of human health," encapsulates their innovative approach to biotechnology.
Recently, Range Biotechnologies secured a $5.20M Seed Round investment on 12 June 2023, indicating strong interest and confidence from leading investors. Notable backers include Pear Ventures, Pillar, Civilization Ventures, Four Cities Capital, Page One Ventures, Hawktail Management, and Artis Ventures (AV). These investors bring not just capital but also significant industry expertise and networks.
Range Biotechnologies is well-positioned at the intersection of biotechnology and healthcare, offering compelling prospects for future growth in translational proteomics.
